SavedAdd your journal

Journals / Eskisehir Medical Journal / 2026 / Volume: 7 Issue: 2

Clinical Characteristics and Metabolic Risk Factors in Pediatric Urolithiasis: A 6-Year Retrospective Analysis

Pediatrik Ürolitiaziste Klinik Özellikler ve Metabolik Risk Faktörleri: Altı Yıllık Retrospektif Bir Analiz

Eren Yaşa(prof dr cemil taşçıoğlu şehir hastanesi çocuk cerrahi ve ürolojisi Kliniği)0000-0002-6211-1529
Hüseyin Emre Atasever(prof dr cemil taşçıoğlu şehir hastanesi çocuk cerrahi ve ürolojisi Kliniği)0000-0002-3511-6797
Duygu Gürel(prof dr cemil taşçıoğlu şehir hastanesi çocuk cerrahi ve ürolojisi Kliniği)0000-0002-2547-8225
Çiğdem Arslan Alıcı(Eskişehir Şehir Hastanesi ÇoCUK üROLOJİSİ ANABİLİM DALI)0000-0001-9152-9636
Doğakan Yiğit(prof dr cemil taşçıoğlu şehir hastanesi çocuk cerrahi ve ürolojisi Kliniği)0000-0001-9863-8560
Ali İhsan Dokucu(prof dr. cemiltaşcıoğlu şehir hastanesi pediatrik cerrahi ve üroloji anabilim dalı)0000-0002-1162-5140
Pages
—
Publication Date
2026-05-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In pediatric stone disease, metabolic evaluation is crucial for identifying underlying disorders and preventing recurrence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Pediatric urinary stone disease is an increasingly common health problem in children and carries a risk of recurrence.
📊
Key Findings & Data:Methods: Pediatric patients diagnosed with urinary stone disease and admitted to our hospital between 2018 and 2024 were retrospectively evaluated.
💡
Conclusion & Impact:Conclusion: In pediatric stone disease, metabolic evaluation is crucial for identifying underlying disorders and preventing recurrence.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Pediatric · urolithiasis · metabolic abnormalities

Abstract

Introduction: Pediatric urinary stone disease is an increasingly common health problem in children and carries a risk of recurrence. Identifying the underlying metabolic abnormalities is crucial for effective treatment and prevention. Methods: Pediatric patients diagnosed with urinary stone disease and admitted to our hospital between 2018 and 2024 were retrospectively evaluated. Clinical data, stone localization and type, as well as metabolic parameters, were assessed through 24-hour urine analyses. Results: A total of 91 patients (59 males, 32 females; mean age: 10.6 years) were included. Renal stones were the most common (75.8%). At least one metabolic abnormality was found in 67.8% of cases, with hypercalciuria (30.8%), hyperoxaluria (17.6%), and hypomagnesuria (11.0%) being the most frequent. Conclusion: In pediatric stone disease, metabolic evaluation is crucial for identifying underlying disorders and preventing recurrence.

Özet

Giriş: Pediatrik üriner sistem taş hastalığı, çocuklarda giderek artan sıklıkla görülen ve tekrarlama riski taşıyan bir sağlık sorunudur. Bu durumun altında yatan metabolik bozuklukların saptanması, tedavi ve önleme açısından önemlidir. Yöntemler: 2018–2024 yılları arasında hastanemize başvuran, üriner sistem taşı tanısı almış çocuk hastaların klinik bulguları, taş özellikleri ve metabolik parametreleri retrospektif olarak 24 saatlik idrar analizleriyle değerlendirildi Bulgular: Toplam 91 hasta (59 erkek, 32 kız; ortalama yaş 10,6 yıl) çalışmaya dahil edildi. Renal taşlar %75,8 ile en sık görülen lokalizasyondu. Hastaların %67,8’inde en az bir metabolik bozukluk saptandı. En sık rastlanan bozukluklar hiperkalsiüri (%30,8), hiperoksalüri (%17,6) ve hipomagnezüri (%11,0) idi. Sonuç: Pediatrik taş hastalığında metabolik değerlendirme, nüksü önlemek ve altta yatan nedenleri belirlemek için kritik öneme sahiptir. Anahtar Kelimeler: Çocukluk çağı, üriner sistem taşı, metabolik bozukluk, hiperkalsiüri, hiperoksalüri

🔖

Cite This Article

Yaşa, E., Atasever, H. E., Gürel, D., Alıcı, Ç. A., Yiğit, D., Dokucu, A. İ. (2026). Clinical Characteristics and Metabolic Risk Factors in Pediatric Urolithiasis: A 6-Year Retrospective Analysis. Eskisehir Medical Journal, Volume: 7 Issue: 2. https://ajindex.com/articles/1614208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (33)

  1. Sas DJ. Clin J Am Soc Nephrol. 2011;6:2062-8.
  2. Kusumi K, Becknell B, Schwaderer A. Pediatr Nephrol. 2015;30:805-10.
  3. Tasian GE, Ross ME, Song L, et al. Clin J Am Soc Nephrol. 2016;11:488-96.
  4. Turney BW, Reynard JM, Noble JG, et al. BJU Int. 2012;109:1082-7.
  5. Tellaloğlu S, Ander H. Turk J Pediatr. 1984;26:51-60.
  6. Noe HN, Stapleton FB, Jerkins GR, Roy S 3rd. J Urol. 1983;129:1166-8.
  7. Stechman MJ, Loh NY, Thakker RV. Pediatr Nephrol. 2009;24:2321-32.
  8. Pearle MS, Goldfarb DS, Assimos DG, et al. J Urol. 2014;192:316-24.
  9. DeFoor W, Minevich E, Jackson E, et al. J Urol. 2008;179:2369-72.
  10. Spivacow FR, Negri AL, del Valle EE, et al. Pediatr Nephrol. 2008;23:1129-33.
  11. DeFoor W, Asplin J, Jackson E, et al. J Urol. 2006;176:1793-6.
  12. Kovacevic L, Wolfe-Christensen C, Edwards L, et al. J Urol. 2012;188:1623-7.
  13. Karabacak OR, Ipek B, Ozturk U, et al. Urology. 2010;76:238-41.
  14. Alpay H, Ozen A, Gokce I, Biyikli N. Pediatr Nephrol. 2009;24:2203-9.
  15. Ghazali S, Barratt TM. Arch Dis Child. 1974;49:97-101.
  16. Stapleton FB, Noe HN, Jenkins G, Roy S 3rd. Pediatrics. 1982;69:594-7.
  17. Srivastava T, Alon US. Adolesc Med Clin. 2005;16:87-109.
  18. Milliner DS. In: Avner ED, Harman WE, Niaudet P, eds. Pediatric Nephrology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1091-112.
  19. Bartosh SM. Urol Clin North Am. 2004;31:575-87.
  20. Önal B, Altınay Kırlı E. Turk Arch Pediatr. 2021;56:93-101.
  21. Milliner DS, Murphy ME. Mayo Clin Proc. 1993;68:241-8.
  22. Ensari E, Onder ENA, Ertan P. Celal Bayar Univ Sag Bil Derg. 2024;11:340-6.
  23. López M, Hoppe B. Pediatr Nephrol. 2010;25:49-59.
  24. Safaei AA, Maleknejad S. Iran J Kidney Dis. 2011;5:309-13.
  25. Dönger U, İncekaş C, Gülleroğlu KS, et al. Turk Arch Pediatr. 2025;60:29.
  26. Lasorsa F, Caliolo C, Silecchia A, et al. Medicina (Kaunas). 2023;59:2165.
  27. Üntan İ, Üntan S, Tosun H, Demirci D. J Pediatr Urol. 2021;17:215.e1.
  28. Spivacow FR, Del Valle EE, Boailchuk JA, et al. Pediatr Nephrol. 2020;35:2107-12.
  29. Rizvi SA, Naqvi SA, Hussain Z, et al. J Urol. 2002;168:1522-5.
  30. Polinsky MS, Kaiser BA, Baluarte HJ. Pediatr Clin North Am. 1987;34:683-710.
  31. Elmacı AM, Ece A, Akın F. J Pediatr Urol. 2014;10:495-9.
  32. Lieberman E. Mayo Clin Proc. 1993;68:313-5.
  33. Edvardsson V, Elidottir H, Olafur S, et al. Pediatr Nephrol. 2005;20:940-4.